HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $695 | -65.5% | 8,160 | -68.2% | 0.09% | -56.4% |
| Q4 2022 | $2,017 | -99.4% | 25,640 | +426.5% | 0.20% | +461.1% |
| Q3 2022 | $361,000 | -49.4% | 4,870 | -55.5% | 0.04% | -55.6% |
| Q2 2022 | $714,000 | +20.6% | 10,950 | -2.0% | 0.08% | +22.7% |
| Q4 2021 | $592,000 | -53.9% | 11,170 | -3.5% | 0.07% | -54.5% |
| Q1 2021 | $1,284,000 | +79.3% | 11,570 | +61.1% | 0.14% | +3.6% |
| Q1 2020 | $716,000 | -68.6% | 7,180 | -63.8% | 0.14% | -61.6% |
| Q4 2019 | $2,277,000 | +163.5% | 19,817 | +189.4% | 0.36% | +140.1% |
| Q3 2019 | $864,000 | -31.9% | 6,847 | -51.6% | 0.15% | -20.4% |
| Q2 2018 | $1,268,000 | +205.5% | 14,145 | +149.8% | 0.19% | +208.1% |
| Q1 2018 | $415,000 | +18.6% | 5,662 | -6.2% | 0.06% | 0.0% |
| Q4 2017 | $350,000 | +61.3% | 6,039 | -19.5% | 0.06% | +5.1% |
| Q2 2016 | $217,000 | -39.6% | 7,500 | -13.4% | 0.06% | -52.8% |
| Q2 2015 | $359,000 | +71.8% | 8,658 | +65.3% | 0.12% | -65.1% |
| Q3 2013 | $209,000 | – | 5,239 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |